A new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...

Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer ...

Hundreds of medcines have become hard or impossible to obtain as the medicine supply crisis deepens - including drugs for ...

Microbeam radiation therapy has proven effective in animal studies against tumours in the brain, breast, skin and central ...

A phase 1 clinical trial co-led by researchers at Washington University School of Medicine in St. Louis found that a new type ...

Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for ...

"During Joe Rogan’s podcast on Jan. 9, Mel Gibson promoted drugs that are not scientifically proven cancer treatments," the ...

Scientists have developed inhalable lung cancer therapeutics utilizing mucoadhesive proteinic nanoparticles.

A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could ...

The most important take-home information from the INTERLACE trial is that in some people with cervical cancer that are ...

A new therapy for the most aggressive type of brain cancer can extend patients' survival while cutting the length of ...

Oncology nurses can educate patients on the benefits of subcutaneous administration, including reduced time in the infusion ...